ebm medical tirzepatide (Zepbound) for the Treatment of Obesity When to use pharmacotherapy for

If you have more severe symptoms such as confusion, loss of consciousness, or seizures, call 911 immediately

N Engl J Med 356:24572471 Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Oliver D, Bacon BR (2003) Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-y ligand rosiglitazone

It is important to note that whilst GLP-1 receptor agonists are not specifically licensed for "menopausal weight gain" as a distinct indication, they may be prescribed for women meeting criteria for obesity treatment or type 2 diabetes management during the menopausal transition

It was I love this place so much